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birds and cars are greater in 
face-selective regions of bird 
and car experts, respectively, 
than in non-experts [17]. 
Behavioral evidence also 
supports a domain-general model 
of processing. For example, dog 
experts show a comparable 
inversion effect — the impaired 
recognition of upside-down 
images — for inverted dogs and 
inverted faces; control subjects 
only show an inversion effect for 
faces [18]. But more recent 
behavioral and neuroimaging 
studies [19,20] have challenged 
these studies and provide 
compelling evidence for a 
domain-specific view of face 
processing. In conclusion, it 
would appear that information 
about faces is represented in 
specialized regions of visual 
cortex, but it is not yet clear how 
other categories of objects are 
represented. 
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Candida albicans Biofilms: More 
Than Filamentation 
Candida albicans is the fungal species most commonly associated with 
biofilm formation in immunosuppressed patients. Recent work offers a 
fresh new look at the role of filamentation in C. albicans biofilm 
formation, and describes the application of a powerful tool for the 
molecular dissection of these important developmental processes. 
José L. López-Ribot 
The majority of microbes in their 
natural habitats are found in biofilm 
ecosystems attached to surfaces 
and not as free-living (planktonic) 
organisms [1]. Formation of 
biofilms is involved in a significant 
proportion of human infections [2], 
including those caused by Candida 
albicans. Candida species are 
frequently found in the normal 
microbiota of humans and do not 
normally cause disease in 
immunocompetent hosts. 
However, immunodepressed 
patients are susceptible to 
candidiasis, which is now the 
fourth most common nosocomial 
infection worldwide with high 
morbidity and mortality rates [3,4]. 
Formation of Candida biofilms 
carries important clinical 
repercussions because of the 
increased antifungal drug 
resistance of these biofilms, their 
ability to resist host immune 
defenses and their potential for 
causing failure of implanted 
devices [5,6]. 
Ultrastructural Characteristics of 
C. albicans Biofilms 
C. albicans biofilm structure has 
been studied mainly in vitro using 
a variety of model systems, in 
work pioneered by the Douglas 
group [7]. Results indicate that 
C. albicans biofilm formation 
occurs through different 
developmental phases that 
include initial attachment and 
colonization, followed by cell 
division, proliferation, and biofilm 
maturation [8,9]. Mature 
C. albicans biofilms show a 
complex three-dimensional 
architecture and display 
extensive spatial heterogeneity, 
consisting of a dense network of 
yeasts, hyphae and 
pseudohyphae encased within a 
matrix of exopolymeric material 
(Figure 1). This structural 
complexity represents the optimal 
spatial arrangement to facilitate 
the influx of nutrients, disposal of 
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Figure 1. Scanning electron 
microscopy image of a 
mature C. albicans biofilm. 
Biofilms are composed of 
yeast, hyphal and pseudo­
hyphal elements. Note that 
the majority of the exopoly­
meric material (matrix) is 
lost due to dehydration 
during SEM procedures. 
Bar = 10 µm. 
waste products and the 
establishment of micro-niches 
throughout the biofilm. 
Importantly, visualization of 
biofilms formed in vivo, in both 
animal models and samples 
retrieved directly from patients, 
seems to corroborate these 
structural observations [10,11]. 
In the last few years molecular 
studies have begun to shed light 
on the driving forces behind the 
transition to the biofilm mode of 
growth in C. albicans [5,12]. Our 
current understanding of the 
mechanisms controlling biofilm 
formation at the molecular level is 
limited, however. The studies by 
Nobile and Mitchell [13], reported 
in this issue of Current Biology, 
describe a novel and powerful 
approach — the use of libraries of 
transcription factor mutants — to 
study key regulatory pathways 
governing complex biological 
processes (Figure 2). By applying 
this technique to examine 
C. albicans biofilm formation, the 
authors unravel the role of key 
transcriptional regulators of this 
developmental process with 
important implications for the 
pathogenesis of candidiasis. 
The Role of Filamentation in 
C. albicans Biofilms 
Without any question, C. albicans 
morphogenetic conversions — 
the ability to reversibly switch 
between yeast and filamentous 
forms — are important for 
multiple aspects of C. albicans 
biology and pathogenicity. 
C. albicans hyphal formation 
occurs in response to distinct 
environmental stimuli and is 
controlled by complex regulatory 
networks [14,15]. Thus, although 
rudimentary yeast-only biofilms 
have been described, 
filamentation seems to play a 
critical role in the development of 
Figure 2. The flow of 
Insights into complex biological processes 
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with a direct role in the resulting phenotype 
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experiments for the use of 
libraries of transcription 




the spatially organized 
architecture seen in mature, 
highly structured C. albicans 
biofilms. 
Evidence for this comes mainly 
from three direct lines of 
observation. First, Baillie and 
Douglas [16] demonstrated that 
hyphae are essential elements for 
providing structural integrity to 
fully developed biofilms. Second, 
Ramage et al. [17] described that 
the efg1∆/efg1∆ mutant, which is 
locked in the yeast form and 
cannot switch to the filamentous 
form, is incapable of forming 
biofilms, thus indicating that the 
Efg1 transcriptional regulatory 
protein is a key factor in the 
formation of mature C. albicans 
biofilms. Third, it was 
demonstrated that farnesol, a 
quorum-sensing molecule that 
blocks filamentation, also inhibits 
biofilm formation [18]. The 
upregulation of many hyphal­
induced genes in biofilms, as 
revealed by gene expression 
profiling studies, corroborates 
these findings [12,19]. The 
anticipated biofilm-forming defect 
of the tec1∆/tec1∆ mutant, which 
is also deficient in hyphal 
development, described here by 
Nobile and Mitchell [13], provides 
further evidence for the role of 
filamentation during biofilm 
formation. 
It has been difficult until now to 
identify specific molecular events 
leading to defects in biofilm 
formation that are independent of 
the filamentation deficiency. 
Nobile and Mitchell [13] go on to 
show that the C. albicans zinc 
finger transcription factor Bcr1p 
regulates biofilm but not hyphae 
formation, a finding of critical 
importance because it 
demonstrates for the first time 
that a C. albicans mutant strain 
that is unable to form biofilms 
can still form filaments normally 
in liquid culture, thus separating 
the processes of filamentation 
and biofilm formation. Indeed, 
microarray analyses indicate that 
the biofilm defect associated with 
the bcr1∆/ bcr1∆ mutant is due to 
inactivation of cell surface 
adhesins, such as Hwp1p and 
Als3p, which may provide the 
necessary interactions to support 
biofilm integrity, indicating a 
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‘functional’ and not ‘structural’ 
defect of hyphal elements 
produced by the mutant strain. 
Moreover, the identification of 
this transcription factor 
transcends the field of biofilm 
research: it allows us to start 
dissecting the filamentation 
pathway(s) where Bcr1p seems 
to act as a downstream 
component of hyphal 
developmental regulators by 
coupling expression of a subset 
of genes encoding cell surface 
proteins to hyphal differentiation. 
From the methodological point 
of view, the construction and 
screening of libraries of 
transcription factor mutants in 
this new study [13] represents a 
clever and creative approach in 
the C. albicans post-genomic era 
that goes one step beyond mere 
gene expression analysis (i.e. 
DNA microarray analysis) to study 
the complex pathways controlling 
pathogenesis. In this strategy, 
mutant strains are created for 
each transcription factor gene 
and the resulting strains are 
tested for phenotypic defects and 
then subjected to microarray 
analysis to identify target genes 
that have a direct role in the 
phenotype under study (Figure 2). 
As the authors of this study [13] 
say, ‘transcription factors play 
pivotal roles in numerous 
developmental pathways, and 
their potential to control 
expression of functionally related 
or redundant genes makes them 
a valuable starting point for 
analysis of biological processes’. 
Thus, this novel screening 
strategy should serve as a 
paradigm for analyses of complex 
biological processes in 
C. albicans and other pathogenic 
microorganisms with sequenced 
genomes. 
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Circadian Biology: Clocks within 
Clocks 
A small cluster of ∼20,000 neurons in the ventral hypothalamus provide 
the body with key time-keeping signals and drive circadian rhythms. 
This circadian clock exhibits surprisingly complex substructures, with 
inputs from the retina, and outputs to other brain structures. Rather 
little is known of the neurotransmitters involved, or their regulation. 
Hugh D. Piggins and specialised neural tract, 
Andrew Loudon originating in the retina and 
terminating in the SCN. The SCN 
In mammals, circadian rhythms of conduct a complex repertoire of 
behaviour and peripheral organ clocks throughout the body, and 
physiology are controlled by their destruction causes an overall 
specialised paired structures loss of circadian synchrony in 
called the suprachiasmatic nuclei both the CNS and in peripheral 
(SCN), located in the ventral tissues and cells. 
region of the hypothalamus, close The distinguished 
to the bottom of the brain. neuroanatomist Robert Moore and 
Perched above the optic chiasm, colleagues [1] proposed that the 
these small nuclei are perfectly SCN should be subdivided into a 
placed to receive photic dorsal ‘shell’ and ventral ‘core’ 
information from the eyes via a (Figure 1). The core receives the 
